Shared Resources - Gene Transfer Vector Core

共享资源-基因转移载体核心

基本信息

  • 批准号:
    8340096
  • 负责人:
  • 金额:
    $ 8.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-08-19 至 2016-03-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY (See instructions): The Gene Transfer Vector Core is integrated into multiple cancer projects directed at the study of the disease process, therapy and the development of vaccines. Vector Core staff are active participants in the development of gene transfer technologies in the cancer field. The interaction with multiple investigators from various disciplines allows for cross-fertilization of ideas, technical advancements, and innovations in vector designs. The Vector Core's overall objective is to support investigators in the use of gene transfer technologies, including consultation with the PI and staff, development of novel vectors, collaborative testing of vectors generated for function and purity, and finally routine preparation including quality control. Vector Core staff and investigators are in close contact through all phases of vector design and generation, and serves as both a research and development facility for gene transfer studies, and a service facility for routine vector preparations. As a part of the service the Vector Core will provide purified and concentrated preparations of recombinant adenovirus, adeno-associated virus (AAV), vaccinia, baculovirus and retrovirus (including lentivirus). This facility provides access to standard cell lines, expression plasmids, and stock of recombinant reporter viruses. The main responsibilities of the Core will be: Prepare recombinant vectors; Quality control; Vector dissemination; Maintain a database of vector stocks available for use; Catalogue plasmid database of expression vectors; develop new expression vectors as needed; Develop novel methods for virus production; Assist in the design and development of novel vectors. This facility serves the needs of numerous outside investigators interested in both basic and applied research with gene transfer vectors, and is important for several reasons. First, by keeping abreast of many different gene transfer vectors, approaches, and applications, the scientific expertise of the Vector Core staff is strengthened. Second, serving a broad scope of users improves and fosters inter-collegiate communication with focused efforts at developing improved vectors and delivery methods. Finally, a continuum of new ideas from both outside and within the university, and through our consultants insures that the Holden Comprehensive Cancer Center community has access to, or is aware of, the 'state of the art'.
项目总结(见说明): 基因转移载体核心被整合到多个癌症项目中,这些项目旨在研究疾病过程、治疗和疫苗开发。Vector Core的工作人员积极参与癌症领域基因转移技术的开发。与来自不同学科的多名研究人员的互动允许在矢量方面的思想,技术进步和创新的交叉施肥 的设计. Vector Core的总体目标是支持研究者使用基因转移技术,包括与PI和工作人员进行咨询,开发新型载体,对所生成的载体进行功能和纯度的协作检测,以及最终的常规制备,包括质量控制。Vector Core工作人员和研究人员在载体设计和生成的所有阶段都保持密切联系, 既是基因转移研究的研发设施,又是常规载体制备的服务设施。作为服务的一部分,Vector Core将提供重组腺病毒、腺相关病毒(AAV)、牛痘、杆状病毒和逆转录病毒(包括慢病毒)的纯化和浓缩制剂。该设施提供了标准细胞系、表达质粒和 重组报告病毒。 核心的主要职责是:制备重组载体;质量控制;载体传播;维护可供使用的载体库存数据库;对表达载体的质粒数据库进行编目;根据需要开发新的表达载体;开发新的病毒生产方法;协助设计和开发新的载体。 该设施满足了许多对基因转移载体的基础和应用研究感兴趣的外部研究人员的需求,并且由于以下几个原因而非常重要。首先,通过了解许多不同的基因转移载体、方法和应用,Vector Core工作人员的科学专业知识得到了加强。第二,服务于广泛的用户,改善和促进校际交流 集中精力开发改进的载体和传递方法。最后,来自大学内外的一系列新想法,并通过我们的顾问确保霍尔顿综合癌症中心社区能够获得或了解“最先进的”。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

George J. Weiner其他文献

275. Immunostimulatory Antigen Loaded Microparticles as Cancer Vaccines
  • DOI:
    10.1016/j.ymthe.2006.08.329
  • 发表时间:
    2006-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Aliasger K. Salem;Anthony D. Sandler;George J. Weiner;Xueqing Zhang;Nicki K. Baman;Xiaoyan Zhu;Christopher E. Dahle
  • 通讯作者:
    Christopher E. Dahle
Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity
  • DOI:
    10.1186/s13045-021-01216-w
  • 发表时间:
    2021-12-01
  • 期刊:
  • 影响因子:
    40.400
  • 作者:
    Zhaoming Wang;Chaobo Yin;Lawrence G. Lum;Andrean Simons;George J. Weiner
  • 通讯作者:
    George J. Weiner

George J. Weiner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('George J. Weiner', 18)}}的其他基金

Program Signaling and Experimental Therapeutics
程序信号传导和实验治疗
  • 批准号:
    8340072
  • 财政年份:
    2011
  • 资助金额:
    $ 8.35万
  • 项目类别:
Shared Resources - Central Microscopy Research Facility
共享资源 - 中央显微镜研究设施
  • 批准号:
    8340157
  • 财政年份:
    2011
  • 资助金额:
    $ 8.35万
  • 项目类别:
Shared Resources - Tissue Procurement
共享资源 - 组织采购
  • 批准号:
    8340168
  • 财政年份:
    2011
  • 资助金额:
    $ 8.35万
  • 项目类别:
Shared Resources - Small Animal Imaging
共享资源 - 小动物成像
  • 批准号:
    8340163
  • 财政年份:
    2011
  • 资助金额:
    $ 8.35万
  • 项目类别:
Clinical Trials Support Core
临床试验支持核心
  • 批准号:
    8340186
  • 财政年份:
    2011
  • 资助金额:
    $ 8.35万
  • 项目类别:
Protocol Specific Research Support
协议特定研究支持
  • 批准号:
    8340201
  • 财政年份:
    2011
  • 资助金额:
    $ 8.35万
  • 项目类别:
Shared Resources - Flow Cytrometry Core
共享资源 - 流式细胞术核心
  • 批准号:
    8340105
  • 财政年份:
    2011
  • 资助金额:
    $ 8.35万
  • 项目类别:
Developmental Funds
发展基金
  • 批准号:
    8340066
  • 财政年份:
    2011
  • 资助金额:
    $ 8.35万
  • 项目类别:
Cancer Epidemiology
癌症流行病学
  • 批准号:
    8340084
  • 财政年份:
    2011
  • 资助金额:
    $ 8.35万
  • 项目类别:
Shared Resources - Bioinformatics
共享资源-生物信息学
  • 批准号:
    8340171
  • 财政年份:
    2011
  • 资助金额:
    $ 8.35万
  • 项目类别:

相似海外基金

cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
  • 批准号:
    10436626
  • 财政年份:
    2021
  • 资助金额:
    $ 8.35万
  • 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10557162
  • 财政年份:
    2021
  • 资助金额:
    $ 8.35万
  • 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
  • 批准号:
    21K08199
  • 财政年份:
    2021
  • 资助金额:
    $ 8.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10330464
  • 财政年份:
    2021
  • 资助金额:
    $ 8.35万
  • 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
  • 批准号:
    9807741
  • 财政年份:
    2019
  • 资助金额:
    $ 8.35万
  • 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2018
  • 资助金额:
    $ 8.35万
  • 项目类别:
    Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
  • 批准号:
    18K15937
  • 财政年份:
    2018
  • 资助金额:
    $ 8.35万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2017
  • 资助金额:
    $ 8.35万
  • 项目类别:
    Discovery Grants Program - Individual
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
  • 批准号:
    1813152
  • 财政年份:
    2016
  • 资助金额:
    $ 8.35万
  • 项目类别:
    Studentship
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
  • 批准号:
    16K09118
  • 财政年份:
    2016
  • 资助金额:
    $ 8.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了